Dugas-Breit, S., Forschner, A., Erdmann, M., Gutzmer, R., Kähler, K. C., Holst, I., . . . Hassel, J. C. (2026). Characteristics and quality of life of nine-year survivors with metastatic melanoma treated with pembrolizumab beyond second-line therapy. European journal of cancer, 233, . https://doi.org/10.1016/j.ejca.2025.116149
Chicago-Zitierstil (17. Ausg.)Dugas-Breit, Susanne, et al. "Characteristics and Quality of Life of Nine-year Survivors with Metastatic Melanoma Treated with Pembrolizumab Beyond Second-line Therapy." European Journal of Cancer 233 (2026). https://doi.org/10.1016/j.ejca.2025.116149.
MLA-Zitierstil (9. Ausg.)Dugas-Breit, Susanne, et al. "Characteristics and Quality of Life of Nine-year Survivors with Metastatic Melanoma Treated with Pembrolizumab Beyond Second-line Therapy." European Journal of Cancer, vol. 233, 2026, https://doi.org/10.1016/j.ejca.2025.116149.